ENDECE PIPELINE

EXPERTS IN DRUG DISCOVERY AND DEVELOPMENT

ENDECE is focused on improving the lives of people suffering from chronic, debilitating, and life-threatening neurological diseases for which treatment options are limited or non-existent. Our library of proprietary compounds is designed to activate multiple genes within specific biological pathways to stop progression, repair damage, and restore function for people with diseases such as Niemann-Pick disease type C (NPC1), Neuromyelitis Optica Spectrum Disorder (NMOSD), Multiple Sclerosis (MS), Osmotic Demyelination Syndrome (ODS), and Alzheimer’s Disease (AD).